Thursday, March 27, 2008 Positive phase III data unveiled for new GnRH blocker degarelix |Read Press Release| Thursday, February 28, 2008 Ferring submits new drug application for degarelix, a prostate cancer treatment |Read Press Release| Wednesday, January 30, 2008 Launch of new infertility and gynaecology research grant (FRIGGA) |Read Press Release| Monday, December 03, 2007 Ferring pharmaceuticals completes phase III study of degarelix in prostate cancer patients |Read Press Release| Tuesday, October 30, 2007 Superior remission rates for once daily use of Pentasa® (mesalazine) in |Read Press Release|

© Copyright Label Ferring. All world rights reserved.

|  Event Calendar |  Global Locator |  Search |  FAQS |  Sitemap |  Legal Disclaimer